Gratus Wealth Advisors’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
1,465,127
+63,140
+5% +$1.53M 5.14% 6
2025
Q4
$34M Buy
1,401,987
+56,512
+4% +$1.37M 4.72% 7
2025
Q3
$32.7M Buy
1,345,475
+37,700
+3% +$914K 4.61% 7
2025
Q2
$31.7M Buy
1,307,775
+25,856
+2% +$624K 4.81% 8
2025
Q1
$31M Buy
1,281,919
+36,699
+3% +$883K 5.09% 7
2024
Q4
$29.8M Buy
1,245,220
+35,309
+3% +$850K 4.77% 6
2024
Q3
$29.2M Buy
1,209,911
+57,461
+5% +$1.38M 4.77% 5
2024
Q2
$27.5M Buy
1,152,450
+4,155
+0.4% +$98.3K 4.74% 6
2024
Q1
$27M Buy
1,148,295
+104,839
+10% +$2.5M 4.96% 5
2023
Q4
$25M Buy
+1,043,456
New +$24.4M 4.92% 4

Other funds holding IBDS

Gratus Wealth Advisors's IBDS Position: Q1 2026 in Review

Gratus Wealth Advisors increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 4.5% in Q1 2026, buying an estimated $1.53M and bringing the position to 1,465,127 shares worth $35.5M. The position accounts for 5.14% of the portfolio, ranked #6.

Gratus Wealth Advisors first reported a position in IBDS in Q4 2023 and has held it in 10 quarters since. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • Gratus Wealth Advisors held 1,465,127 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $35.5M as of Q1 2026.
  • Gratus Wealth Advisors bought 63,140 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $1.53M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 5.14% of Gratus Wealth Advisors's portfolio in Q1 2026, its #6 holding.
  • Gratus Wealth Advisors first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Gratus Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.